Abstract
Pilot Study of Non-Viral, RNA-Redirected Autologous Anti-CD19 Chimeric Antigen Receptor Modified T-Cells in Patients with Refractory/Relapsed Hodgkin Lymphoma (HL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have